169 related articles for article (PubMed ID: 19527447)
1. Obesity, the PI3K/Akt signal pathway and colon cancer.
Huang XF; Chen JZ
Obes Rev; 2009 Nov; 10(6):610-6. PubMed ID: 19527447
[TBL] [Abstract][Full Text] [Related]
2. Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication.
Uddin S; Bavi PP; Hussain AR; Alsbeih G; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Ahmed M; Al-Kuraya KS
Carcinogenesis; 2009 Nov; 30(11):1832-40. PubMed ID: 19520793
[TBL] [Abstract][Full Text] [Related]
3. From Rapa Nui to rapamycin: targeting PI3K/Akt/mTOR for cancer therapy.
Georgakis GV; Younes A
Expert Rev Anticancer Ther; 2006 Jan; 6(1):131-40. PubMed ID: 16375650
[TBL] [Abstract][Full Text] [Related]
4. IGF-1 protects oligodendrocyte progenitors against TNFalpha-induced damage by activation of PI3K/Akt and interruption of the mitochondrial apoptotic pathway.
Pang Y; Zheng B; Fan LW; Rhodes PG; Cai Z
Glia; 2007 Aug; 55(11):1099-107. PubMed ID: 17577243
[TBL] [Abstract][Full Text] [Related]
5. IGF-1 activates hEAG K(+) channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation.
Borowiec AS; Hague F; Harir N; Guénin S; Guerineau F; Gouilleux F; Roudbaraki M; Lassoued K; Ouadid-Ahidouch H
J Cell Physiol; 2007 Sep; 212(3):690-701. PubMed ID: 17520698
[TBL] [Abstract][Full Text] [Related]
6. Multiple signal pathways in obesity-associated cancer.
Chen J
Obes Rev; 2011 Dec; 12(12):1063-70. PubMed ID: 22093240
[TBL] [Abstract][Full Text] [Related]
7. Lycopene inhibits growth of human colon cancer cells via suppression of the Akt signaling pathway.
Tang FY; Shih CJ; Cheng LH; Ho HJ; Chen HJ
Mol Nutr Food Res; 2008 Jun; 52(6):646-54. PubMed ID: 18537129
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells.
Wang J; Yang L; Yang J; Kuropatwinski K; Wang W; Liu XQ; Hauser J; Brattain MG
Cancer Res; 2008 May; 68(9):3152-60. PubMed ID: 18451140
[TBL] [Abstract][Full Text] [Related]
9. Targeting the phosphatidylinositol-3 kinase/Akt pathway for the treatment of cancer.
Kim D; Cheng GZ; Lindsley CW; Yang H; Cheng JQ
Curr Opin Investig Drugs; 2005 Dec; 6(12):1250-8. PubMed ID: 16370391
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of SCLC growth by the A12 anti-IGF-1R monoclonal antibody correlates with inhibition of Akt.
Yeh J; Litz J; Hauck P; Ludwig DL; Krystal GW
Lung Cancer; 2008 May; 60(2):166-74. PubMed ID: 18006183
[TBL] [Abstract][Full Text] [Related]
11. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway.
Chen C; Chang YC; Liu CL; Liu TP; Chang KJ; Guo IC
Endocr Relat Cancer; 2007 Jun; 14(2):513-29. PubMed ID: 17639064
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
13. Differential roles of phosphatidylinositol 3-kinase/akt pathway in retinal ganglion cell survival in rats with or without acute ocular hypertension.
Huang Y; Cen LP; Luo JM; Wang N; Zhang MZ; van Rooijen N; Pang CP; Cui Q
Neuroscience; 2008 Apr; 153(1):214-25. PubMed ID: 18358617
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylinositol-3-kinase/Akt signaling pathway and kidney cancer, and the therapeutic potential of phosphatidylinositol-3-kinase/Akt inhibitors.
Porta C; Figlin RA
J Urol; 2009 Dec; 182(6):2569-77. PubMed ID: 19836781
[TBL] [Abstract][Full Text] [Related]
15. Obesity-induced metabolic stresses in breast and colon cancer.
Sung MK; Yeon JY; Park SY; Park JH; Choi MS
Ann N Y Acad Sci; 2011 Jul; 1229():61-8. PubMed ID: 21793840
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of PI3K/Akt partially leads to the inhibition of PrP(C)-induced drug resistance in gastric cancer cells.
Liang J; Ge F; Guo C; Luo G; Wang X; Han G; Zhang D; Wang J; Li K; Pan Y; Yao L; Yin Z; Guo X; Wu K; Ding J; Fan D
FEBS J; 2009 Feb; 276(3):685-94. PubMed ID: 19143835
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylinositol 3-kinase/Akt signaling stimulates colonic mucosal cell survival during aging.
Majumdar AP; Du J
Am J Physiol Gastrointest Liver Physiol; 2006 Jan; 290(1):G49-55. PubMed ID: 16123202
[TBL] [Abstract][Full Text] [Related]
18. The Src/PI3K/Akt pathway may play a key role in the production of IL-17 in obesity.
Chen J
J Leukoc Biol; 2010 Mar; 87(3):355; author reply 357. PubMed ID: 20194159
[No Abstract] [Full Text] [Related]
19. Estrogen in obesity-associated colon cancer: friend or foe? Protecting postmenopausal women but promoting late-stage colon cancer.
Chen J; Iverson D
Cancer Causes Control; 2012 Nov; 23(11):1767-73. PubMed ID: 23011535
[TBL] [Abstract][Full Text] [Related]
20. Obesity and cancer.
Percik R; Stumvoll M
Exp Clin Endocrinol Diabetes; 2009 Nov; 117(10):563-6. PubMed ID: 19924603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
